| 2017 | Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement. | 김주항, 김혜련, 심효섭, 임선민, 조병철 |
| 2017 | A randomized; phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) (vol 8; pg 15943; 2017)
| 김주항, 김혜련, 정인경, 조병철 |
| 2016 | Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer
| 금기창, 김세헌, 김주항, 김준원, 이창걸 |
| 2016 | Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy | 김주항, 김혜련, 박형순, 이민구, 조병철, 조응혁 |
| 2016 | Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells | 김주항, 송재진, 최혜진 |
| 2016 | Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer.
| 김영진, 김주항, 문용화, 서영주, 심효섭, 이혜정, 임동진, 조응혁, 최병욱, 허진, 홍유진 |
| 2016 | Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma | 고윤우, 김주항, 김혜련, 이창걸, 조병철, 최은창 |
| 2015 | Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck | 고윤우, 권형주, 김주항, 김한상, 김혜련, 백순명, 이민구, 이지현, 정인경, 조병철, 최은창 |
| 2015 | Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells | 김주항, 송재진, 최혜진 |
| 2015 | Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest | 김주항, 송재진 |
| 2015 | Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma.
| 김대준, 김주항, 김현기, 김혜련, 김효송, 박준철, 신성관, 이상길, 이용찬, 이창걸, 정다현, 조병철, 허진 |
| 2015 | Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implication
| 구자승, 김민환, 김승일, 김주항, 박병우, 박세호, 박형석, 손주혁, 정준 |
| 2015 | The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer | 김대준, 김세규, 김은영, 김주항, 김혜련, 김효송, 심효섭, 이창영, 장준, 정인경, 정지예, 조병철 |
| 2015 | An open label, multicenter, phase II study of dovitinib in advanced thyroid cancer | 강상욱, 강찬우, 김주항, 김혜련, 남기현, 임선민, 임재윤, 정웅윤, 조병철 |
| 2015 | LAMC2 enhances the metastatic potential of lung adenocarcinoma | 김주항, 문용화, 심효섭, 정현철 |
| 2015 | Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma
| 강찬우, 강한나, 김대준, 김주항, 김혜련, 김환, 문용화, 백순명, 윤미란, 임선민, 장강원, 조병철, 표경호 |
| 2015 | Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma
| 김대준, 김주항, 김현기, 김혜련, 김효송, 문용화, 박준철, 백순명, 신성관, 이상길, 이용찬, 이창걸, 정현수, 조병철, 표경호, 허진 |
| 2014 | Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma | 김대준, 김세규, 김주항, 김혜련, 심효섭, 임선민, 장준, 조병철 |
| 2014 | A prospective phase II trial of s-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer | 김대준, 김주항, 김충배, 김형일, 김혜련, 박준철, 배미경, 신성관, 이상길, 이용찬, 이진구, 이창걸, 이창영, 이혁, 조병철, 차지혜, 허진 |
| 2014 | Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma | 김대준, 김민환, 김은영, 김주항, 김현정, 김혜련, 배미경, 심효섭, 이진구, 이창영, 임선민, 정경영, 정지예, 조병철 |
| 2014 | Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations | 강대용, 김민환, 김은영, 김주항, 김혜련, 배미경, 이재석, 이창영, 조병철 |
| 2014 | Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers
| 김대준, 김세규, 김은영, 김주항, 김한상, 김혜련, 배미경, 심효섭, 이민구, 이지현, 이진구, 이창영, 장준, 정경영, 정지예, 조병철 |
| 2014 | Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial. | 김주항 |
| 2014 | Clinical Outcome According to the Level of Preexisting Epidermal Growth Factor Receptor T790M Mutation in Patients With Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations | 김주항 |
| 2014 | Tumor MET expression profile predicts the outcome of non-small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitors | 김주항, 박희진, 조병철 |
| 2014 | Establishment of a mouse melanoma model system for the efficient infection and replication of human adenovirus type 5-based oncolytic virus | 김주항, 송재진 |
| 2013 | TRAIL/MEKK4/p38/HSP27/Akt survival network is biphasically modulated by the Src/CIN85/c-Cbl complex | 김주항, 송재진 |
| 2013 | A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC) | 김선미, 김세현, 김주항, 김혜련, 심효섭, 장현, 조병철, 조재호, 홍윤경 |
| 2013 | Transforming growth factor-β gene silencing using adenovirus expressing TGF-β1 or TGF-β2 shRNA | 김주항, 송재진 |
| 2013 | c-Cbl shRNA-expressing adenovirus sensitizes TRAIL-induced apoptosis in prostate cancer DU-145 through increases of DR4/5 | 김주항, 송재진 |
| 2013 | The effectiveness of the oncolytic activity induced by Ad5/F35 adenoviral vector is dependent on the cumulative cellular conditions of survival and autophagy | 김주항, 송재진 |
| 2013 | Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer | 강대용, 김대준, 김세훈, 김주항, 김혜련, 라선영, 배미경, 심효섭, 이지현, 이진구, 이창영, 임선민, 정경영, 조병철 |
| 2013 | Crosstalk from survival to necrotic death coexists in DU-145 cells by curcumin treatment: Inhibition of apoptosis by caspase degradation. | 김주항, 송재진 |
| 2013 | The Impact of Cigarette Smoking on the Frequency of and Qualitative Differences in KRAS Mutations in Korean Patients with Lung Adenocarcinoma
| 김주항, 김혜련, 남기창, 라선영, 안정련, 이진구, 조병철, 홍윤경 |
| 2013 | Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer | 김건민, 김다래, 김세규, 김세현, 김영삼, 김은영, 김주항, 김한상, 김혜련, 박무석, 박지수, 이준호, 임선민, 임승택, 장준, 정지예, 조병철 |
| 2013 | The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma
| 김주항, 김혜련, 배미경, 심효섭, 조병철 |
| 2013 | Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors
| 김주항, 김한상, 김효송, 노재경, 라선영, 손주혁, 신상준, 안중배, 이수현, 정현철, 조병철, 최혜진 |
| 2013 | Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung
| 강영애, 김대준, 김세규, 김주항, 라선영, 박형순, 이지현, 이철호, 장준, 정민규, 조병철 |
| 2013 | Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer
| 강창무, 김주항, 송시영, 윤미진, 이우정, 이재훈, 이종두, 조응혁, 최혜진 |
| 2013 | Better Outcome of XELOX Chemotherapy in Patients with Advanced Intestinal-Type Adenocarcinoma of the Ampulla of Vater
| 김주항, 김한상, 김현기, 신상준, 최혜진 |
| 2013 | Glycolysis Inhibition Sensitizes Non–Small Cell Lung Cancer with T790M Mutation to Irreversible EGFR Inhibitors via Translational Suppression of Mcl-1 by AMPK Activation | 김선미, 김주항, 조병철 |
| 2013 | S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial
| 구자승, 김민정, 김승일, 김은경, 김주항, 박병우, 박세호, 손주혁, 이수현, 정현철 |
| 2013 | Prolonged clinical benefit from the maintenance hormone therapy in patients with metastatic breast cancer | 김승일, 김주항, 박병우, 박세호, 손주혁, 이수현, 임승택, 최혜진, 한정우 |
| 2013 | A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes | 강상욱, 김주항, 김현정, 남기현, 박정수, 윤미진, 임선민, 정웅윤, 조병철 |
| 2012 | Phase II study of cisplatin with irinotecan as induction chemotherapy followed by chemoradiotherapy for unresectable stage III non-small cell lung cancer | 김세현, 김주항, 김혜련, 윤상현, 이창걸, 장현, 조병철 |
| 2012 | Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancer
| 김세규, 김영진, 김주항, 김희영, 남지은, 이혜선, 이혜정, 장준, 정경영, 최병욱, 허진, 홍유진 |
| 2012 | Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.
| 김세규, 김세훈, 김주항, 김혜련, 라선영, 심효섭, 정경영, 조병철, 홍윤경 |
| 2012 | The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma. | 고윤우, 김건민, 김선미, 김세헌, 김주항, 김한상, 김혜련, 김효송, 조병철, 최은창 |
| 2012 | HSP27 modulates survival signaling networks in cells treated with curcumin and TRAIL. | 김주항, 송재진 |
| 2012 | High EGFR gene copy number and skin rash as predictive markers for EGFR tyrosine kinase inhibitors in patients with advanced squamous cell lung carcinoma.
| 김세훈, 김주항, 박무석, 심효섭, 조병철 |
| 2012 | Efficacy and toxicity of belotecan for relapsed or refractory small cell lung cancer patients | 강영애, 김건민, 김선미, 김세규, 김영삼, 김주항, 임승택, 조병철 |
| 2012 | Activation of IL-6R/JAK1/STAT3 signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation | 권오준, 김선미, 김주항, 이지현, 조병철, 홍윤경 |
| 2012 | Overexpression of class III beta tubulin and amplified HER2 gene predict good response to paclitaxel and trastuzumab therapy
| 구자승, 김승일, 김주항, 라선영, 문용화, 박병우, 박세호, 손주혁, 이수현, 정민규, 정현철, 홍수정 |
| 2012 | Treatment outcome of patients with anaplastic thyroid cancer: a single center experience
| 강상욱, 금기창, 김주항, 남기현, 박정수, 신상준, 임선민, 정웅윤, 조병철, 조재용 |
| 2012 | EGFR polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI
| 강영애, 김대준, 김세규, 김주항, 라선영, 박형순, 이지현, 이철호, 장준, 정민규, 조병철 |
| 2011 | TRAIL-induced caspase/p38 activation is responsible for the increased catalytic and invasive activities of Akt
| 김소영, 김주항, 선보경, 송재진, 오세은, 응구엔응옥호안 |
| 2011 | MEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylation
| 김소영, 김주항, 선보경, 송재진, 오세은, 응구엔응옥호안, 최혜진 |
| 2011 | Lung cancer in never smokers: change of a mindset in the molecular era. | 김세규, 김주항, 조병철 |
| 2011 | A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results. | 권지은, 김세규, 김주항, 박무석, 손주혁, 심효섭, 양우익, 이익재, 이주희, 이창걸, 최혜진 |
| 2011 | Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer | 김세규, 김영진, 김주항, 김화선, 김희영, 남지은, 이혜정, 장준, 정경영, 최규옥, 최병욱, 허진, 홍유진 |
| 2011 | Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib.
| 강영애, 김대준, 김세규, 김세현, 김주항, 라선영, 이영주, 장준, 정민규, 조병철, 홍수정 |
| 2011 | An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia. | 김주항 |
| 2011 | Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan | 김주항 |
| 2011 | Comparative effectiveness of bevacizumab plus cisplatin-based chemotherapy versus pemetrexed plus cisplatin treatment in East Asian non-squamous non-small cell lung cancer patients applying real-life outcomes | 김주항 |
| 2011 | A randomized phase 3 trial comparing pemetrexed/carboplatin and docetaxel/carboplatin as first-line treatment for advanced, nonsquamous non-small cell lung cancer | 김주항 |
| 2010 | The role of monoclonal antibody in combination with first-line chemotherapy in Asian patients with advanced non-small cell lung cancer
| 김주항, 조병철 |
| 2010 | Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer. | 김세규, 김주항, 문진욱, 박인규, 이영주, 장준, 정경영, 조병철, 지선하 |
| 2010 | Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer | 김귀언, 김주항, 손주혁, 이영주, 이창걸, 조병철, 최은창, 최혜진 |
| 2010 | Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer.
| 김세규, 김주항, 문진욱, 박인규, 이영주, 장준, 조병철, 최혜진 |
| 2010 | Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL
| 김주항, 김호근, 윤채옥, 이민걸, 장송남, 최경주, 최일규 |
| 2010 | Acquired resistance to cetuximab is mediated by increased PTEN instability and leads cross-resistance to gefitinib in HCC827 NSCLC cells. | 김선미, 김주항, 김지수, 김현기, 윤채옥, 조병철, 최수영 |
| 2010 | Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance | 구자승, 김승일, 김주항, 노재경, 문용화, 박병우, 박세호, 손주혁, 장현, 정현철, 최혜진 |
| 2010 | Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: a phase II trial | 김세규, 김세현, 김주항, 박무석, 손주혁, 신상준, 장준, 정민규, 정재헌, 조병철, 최혜진 |
| 2010 | Randomized Phase III trial of gefitinib versus docetaxel in non-small cell lung cancer patients who have previously received platinum-based chemotherapy
| 김주항 |
| 2010 | Dose effect of cigarette smoking on frequency and spectrum of epidermal growth factor receptor gene mutations in Korean patients with non-small cell lung cancer. | 강영애, 김세규, 김주항, 김현기, 김호근, 심효섭, 조병철, 홍수정 |
| 2010 | Prognostic factors in small cell lung cancer: a new prognostic index in Korean patients | 김세규, 김주항, 박경수, 이수현, 정민규, 조병철, 최혜진, 홍수정 |
| 2009 | Phase II study of transarterial holmium-166-chitosan complex treatment in patients with a single, large hepatocellular carcinoma | 김주항, 박경수, 손주혁, 유내춘, 이종두, 이종태, 최혜진 |
| 2009 | Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma. | 김세규, 김주항, 김호근, 문진욱, 박무석, 박인규, 장준, 정경영, 조병철, 최혜진 |
| 2009 | High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer.
| 김세규, 김주항, 문진욱, 박인규, 윤미진, 장준, 조병철, 최혜진 |
| 2009 | Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect | 김주항, 김평환, 성진실, 윤채옥, 최혜진 |
| 2009 | Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck | 금기창, 김세헌, 김주항, 신상준, 조병철, 최은창, 최혜진 |
| 2009 | 비소세포성 폐암으로 수술 후 방사선치료가 시행된 N2병기 환자들에서 다발 부위 종격동 림프절 전이 여부에 따른 N2병기 구분의 임상적 의미
| 김용배, 김주항, 이익재, 이진구, 이창걸, 정경영, 조병철 |
| 2009 | Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided versus empirical chemotherapy in unresectable non-small cell lung cancer
| 김세규, 김주항, 문용화, 손주혁, 이영주, 장준, 장현, 정민규, 정재헌, 홍수정 |
| 2009 | Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study | 김주항 |
| 2009 | Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC | 김세현, 김주항, 손주혁, 신상준, 유내춘, 조병철, 최혜진 |
| 2009 | Complete response of recurrent squamous cell carcinoma of the lung: dose the dose matter? | 김광준, 김주항, 김현기, 신상훈, 이영주, 조병철, 최혜진 |
| 2008 | Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients
| 김남규, 김주항, 노재경, 성진실, 손주혁, 안중배, 정현철, 조병철 |
| 2008 | A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features | 김대준, 김범경, 김세규, 김주항, 박무석, 손주혁, 유내춘, 이창걸, 장준, 정경영, 조병철, 최혜진 |
| 2008 | Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy. | 김세규, 김주항, 손주혁, 신상준, 장준, 전성하, 정종열, 조병철, 최혜진 |
| 2008 | Novel cancer antiangiotherapy using the VEGF promoter-targeted artificial zinc-finger protein and oncolytic adenovirus | 강윤아, 김주항, 유지영, 윤채옥 |
| 2008 | Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition | 강윤아, 김재성, 김주항, 윤채옥 |
| 2008 | The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLC. | 김대준, 김세규, 김세현, 김주항, 박무석, 손주혁, 신상준, 장준, 정경영, 조병철, 최혜진 |
| 2007 | Hybrid nanoparticles for magnetic resonance imaging of target-specific viral gene delivery | 김주항, 김평환, 서진석, 윤채옥, 이은숙, 허용민 |
| 2007 | Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung
| 강신명, 강현주, 김성규, 김세규, 김주항, 김호근, 신동환, 장준, 정경영 |
| 2007 | Adenosine Tiphosphate-based Chemotherapy Response Assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer
| 김세규, 김용태, 김주항, 문용화, 박무석, 손주혁, 정경영 |
| 2007 | Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer
| 김귀언, 김세규, 김영삼, 김주항, 문용화, 손주혁, 이창걸, 장준, 정경영, 최병욱, 최혜진 |
| 2007 | Treatment outcomes of 70 cases of early esophageal carcinoma: 12 years of experience | 김주항, 김충배, 박승우, 송시영, 윤영훈, 이용찬, 정재복 |
| 2007 | E1A- and E1B-double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects | 김재성, 김주항, 김평환, 윤채옥, 최경주 |
| 2007 | Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type | 금웅섭, 김귀언, 김용배, 김주항, 서창옥, 심수정, 양우익, 조재호 |
| 2007 | Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib | 김세규, 김유진, 김주항, 김호근, 박무석, 박종필, 손주혁, 신상준, 임종근, 장준, 조병철, 최혜진 |
| 2007 | Retargeting of adenoviral gene delivery via Herceptin-PEG-adenovirus conjugates to breast cancer cells | 김주항, 손주혁, 양재문, 윤채옥, 허용민 |
| 2007 | VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth | 김남규, 김주항, 유지영, 윤채옥, 최혜진 |
| 2007 | Multi-disciplinary treatment of a rare pelvic cavity ependymoma
| 김주항, 김태승, 손주혁, 한승진, 황혜진 |
| 2006 | Comparison of stage-specific outcome of breast cancer based on 5th and 6th AJCC staging system | 김귀언, 김승일, 김주항, 박병우, 양우익, 이경식 |
| 2006 | The changes of estrogen receptor-β variants expression in breast carcinogenesis: Decrease of estrogen receptor-β2 expression is the key event in breast cancer development | 김귀언, 김승일, 김주항, 박병우, 양우익 |
| 2006 | Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect | 김귀언, 김주항, 김호근, 손주혁, 윤채옥 |
| 2006 | Markedly Enhanced Cytolysis by E1B-19kD-Deleted Oncolytic Adenovirus in Combination with Cisplatin | 김주항, 김호근, 박병우, 손주혁, 윤채옥 |
| 2006 | Enhanced Antitumor Effect of Oncolytic Adenovirus Expressing Interleukin-12 and B7-1 in an Immunocompetent Murine Model
| 김주항, 김호근, 윤채옥 |
| 2006 | Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy
| 김주항, 김호근, 윤채옥 |
| 2006 | Paclitaxel and leucovorin-modulated infusional 5-fluorouracil combination chemotherapy for metastatic gastric cancer | 김주항, 김충배, 손주혁, 안중배, 이용찬 |
| 2006 | A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer | 김대준, 김세규, 김주항, 손주혁, 이창걸, 장준, 정경영 |
| 2006 | Generation of a rabbit VH domain antibody polyspecific to c-Met and adenoviral knob protein | 김주항, 윤채옥 |
| 2005 | A Pilot Study of Trans-Arterial Injection of 166Holmium-Chitosan Complex for Treatment of Small Hepatocellular Carcinoma
| 김주항, 노재경, 손주혁, 안중배, 유내춘, 이종두, 이종태, 정현철, 조병철, 최혜진 |
| 2005 | Correlation of KIT and platelet-derived growth factor receptor α mutations with gene activation and expression profiles in gastrointestinal stromal tumors | 강현주, 김주항, 김현기, 김혜령, 김호근, 노성훈, 윤채옥, 이환석, 형우진 |
| 2005 | E1A/E1B 이중변이형 종양 선택적 살상 아데노바이러스의 개선된 암세포 살상 효과 및 항종양 효과
| 김재성, 김주항, 김평환, 손주혁, 윤채옥, 최경주 |
| 2005 | Coxsackie and adenovirus receptor binding ablation reduces adenovirus liver tropism and toxicity | 김귀언, 김민정, 김주항, 김호근, 유지영, 윤아름, 윤채옥 |
| 2005 | ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis | 구태영, 김은희, 김주항, 김호근, 윤채옥, 이영숙 |
| 2005 | A Feasibility Study of Adenosine Triphosphate-based Chemotherapy Response Assay (ATP-CRA) as a Chemosensitivity Test for Lung Cancer
| 강신명, 김대준, 김세규, 김주항, 김혜령, 박무석, 손주혁, 신동환, 장준, 정경영 |
| 2005 | Usefulness of Bone Metabolic Markers in the Diagnosis of Bone Metastasis from Lung Cancer
| 김성규, 김세규, 김영삼, 김주항, 박무석, 장준 |
| 2005 | De novo osteogenesis from human ligamentum flavum by adenovirus-mediated bone morphogenetic protein-2 gene transfer | 김주항, 문성환, 박시영, 양익환, 윤채옥, 이환모 |
| 2004 | Lack of Correlation Between P-glycoprotein and Chemotherapy Resistance in Nasal NK/T-cell Lymphomas | 김귀언, 김주항, 노재경, 라선영, 서창옥, 양우익, 유내춘, 이상욱, 정현철, 조재호, 한지숙 |
| 2004 | Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis | 금기창, 금웅섭, 김귀언, 김주항, 노재경, 서창옥, 양우익, 이상욱, 이창걸, 한지숙 |
| 2004 | Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification | 김세규, 김주항, 박무석, 양우익 |
| 2004 | 악성 흉막액에서 CEA와 CYFRA 21-1의 진단적 유용성
| 김성규, 김세규, 김영삼, 김주항, 문진욱, 박무석, 장준, 정재호, 황상연 |
| 2003 | Clinical features of bronchogenic large cell carcinoma confirmed by surgical resection.
| 김도훈, 김성규, 김세규, 김영삼, 김주항, 박무석, 신동환, 장준, 정경영, 정재호, 정재희 |
| 2003 | Optimization of vesicular stomatitis virus-G pseudotyped feline immunodeficiency virus vector for minimized cytotoxicity with efficient gene transfer | 김주항, 송재진, 장진우 |
| 2003 | dl-VSVG-LacZ, a VSV-G epitope incorporated adenoviurs exhibit marked enhancement in gene transduction efficiency | 김주항, 손주혁, 송재진, 윤채옥 |
| 2003 | Increased Cytopathic Effect of Replicating Adenovirus Expressing Adenovirus Death Protein
| 김주항, 손주혁, 윤채옥 |
| 2003 | A Case of Paraneoplastic Nephrotic Syndrome in a Patient with Ovarian Carcinoma
| 김용태, 김주항, 김철, 노재경, 라선영, 손주혁, 심지영, 유내춘, 정현철, 한대석 |
| 2003 | Ad-mTERT-Δ19, a Conditional Replication-Competent Adenovirus Driven by the Human Telomerase Promoter, Selectively Replicates in and Elicits Cytopathic Effect in a Cancer Cell-Specific Manner | 김주항, 김호근, 손주혁, 윤채옥 |
| 2002 | 폐암에 의한 악성 흉막삼출환자에서 OK-432와 Doxycycline 흉막유착술의 비교
| 곽승민, 김성규, 김세규, 김영삼, 김주항, 박무석, 장준, 정재호, 정재희 |
| 2002 | Evaluation of E1b gene-attenuated replicating adenoviruses for cancer gene therapy
| 김주항, 윤채옥, 조재용 |
| 2002 | Identification of MARCKS, FLJ11383 and TAF1B as putative novel target genes in colorectal carcinomas with mocrosatellite instability
| 김주항, 김호근, 이진성 |
| 2002 | Antitumoral effects of recombinant adenovirus YKL-1001, conditionally replicating in α-fetoprotine-producing human liver cancer cells | 김주항, 윤채옥 |
| 2001 | CD5와 Cytokeratin 7에 음성이고 Cytokeratin 13에 양성인 흉선 편평상피세포암 1예
| 김성규, 김세규, 김영삼, 김주항, 노태웅, 박무석, 손주혁, 신동환, 장준, 정경영, 정재호 |
| 2001 | Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck | 김귀언, 김주항 |
| 2001 | Evaluation of E1B - mutant Replicating Adenoviruses for Cancer Gene Therapy
| 김주항, 윤채옥 |
| 2001 | Efficient gene transfer of VSV-G pseudotyped retroviral vector to human brain tumor
| 김주항, 송재진, 윤채옥, 장진우 |
(Yonsei Health Research Network)
